Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,034,845
+$3,827,814 QoQ
Shares Held
313,083
+1.7% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#99
of 751 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mariner, LLC holds $489,961,577 across 152 Biotechnology names. EXEL ranks #5 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
608,615 | $146,657,956 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
134,614 | $66,866,811 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
100,086 | $62,407,624 | |
| 4 | RPRX |
Royalty Pharma plc
|
693,495 | $38,884,263 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
313,083 | $17,034,845 | |
| 6 | INCY |
Incyte Corp
|
121,988 | $13,828,559 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
192,607 | $11,020,972 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
28,021 | $8,435,161 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,034,845 | 313,083 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $13,207,031 | 307,928 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $11,733,159 | 267,697 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,233,087 | 78,283 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,731,240 | 61,961 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,325,464 | 35,901 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $678,420 | 20,373 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $467,567 | 18,018 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $425,379 | 18,931 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $442,944 | 18,666 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $404,783 | 16,873 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $435,973 | 19,953 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $340,922 | 17,840 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $316,654 | 16,314 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $421,659 | 26,288 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $378,029 | 24,109 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $501,283 | 24,077 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $573,959 | 25,318 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $398,833 | 21,818 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $431,615 | 20,417 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $343,046 | 18,828 | Shares | Sole | 2021-08-24 | |
| 2021-03-31 | $443,577 | 19,636 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $410,913 | 20,474 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $353,498 | 14,458 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $355,031 | 14,955 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $239,409 | 13,903 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||